By the end of 2018, through 10 years of continuous research and development, we have successfully developed : Small molecule targeted anti-tumor products: 21 projects ,such as Gefitinib, Erlotinib, Pazopanib, Lapatinib, Afatinib, Lenvatinib,etc; Diabetes products: 16 items ,such as Sitagliptin, Linagliptin,Alogliptin, Dapagliflozin, and Canagliflozin,etc; Anti-Cardiovascular products: 7 projects ,including Apixaban, Rivaroxaban, Betrixaban, and Dofetilide;
ANQING CHICO PHARMACEUTICAL CO.,LTD.
Country: 
China (Mainland)
Business Type: Trading Company
Premiumsupplier
Ms.JIANG
Tel: +86-13057662806
4-(6-Nitro-3-pyridinyl)-1-piperazinecarboxylic acid tert-butyl esterCAS NO.: 571189-16-7
5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinamineCAS NO.: 1180132-17-5
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl esterCAS NO.: 211915-84-3
(2E)-3-(Dimethylamino)-1-(3-pyridyl)prop-2-en-1-oneCAS NO.: 123367-26-0
3-Ethynylaniline hydrochlorideCAS NO.: 207226-02-6
7-Chloro-N-(3-chloro-4-fluorophenyl)-6-nitro-4-quinazolinamineCAS NO.: 179552-73-9
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dioneCAS NO.: 853029-57-9
(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one.HClCAS NO.: 898543-06-1
5-Bromo-2-chloro-4-(cyclopentylamino)pyrimidineCAS NO.: 733039-20-8
